Novartis Pharma B.V.
Location
Noord-Holland
Founded
1948-02-10
Website
Risk Signals
21160 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Novartis Pharma B.V.
Live alerts from global media, monitored by Business Radar
2024-09-20 (ladepeche.fr)
AZF: first projects on the wastelands around the explosion crater, arrival of Novartis on the Oncopole side
The decontamination of the surroundings of the crater of the AZF explosion allows, 23 years after the disaster, to glimpse the future of these wastelands. On the Oncopole side, projects are multiplying: inauguration of the Evotec factory and arrival...
Read more
2024-09-20 (ladepeche.fr)
AZF: first projects on the wastelands around the explosion crater, arrival of Novartis on the Oncopole side
The decontamination of the surroundings of the crater of the AZF explosion allows, 23 years after the disaster, to glimpse the future of these wastelands. On the Oncopole side, projects are multiplying: inauguration of the Evotec factory and arrival...
Read more
2023-10-31 (ticinonews.ch)
Bombing in Jabalya refugee camp, medical sources: "Hundreds dead"
All the updates on the situation in the Middle East in our live broadcast.
Read more
2023-05-22 (sharedeals.de)
AVROBIO +99% after Novartis deal: price explosion with announcement! › sharedeals.de
Some of the rumors surrounding our small-cap pick AVROBIO (NASDAQ:AVROBIO) have come true. Although the pharmaceutical giant takes over Novartis ...
Read more
2023-05-22 (sharedeals.de)
AVROBIO +99% after Novartis deal: price explosion with announcement! › sharedeals.de
Some of the rumors surrounding our small-cap pick AVROBIO (NASDAQ:AVROBIO) have come true. Although the pharmaceutical giant takes over Novartis ...
Read more
(golocalprov.com)
GoLocalProv | Health | NEW: Novartis Recalls Excedrin, NoDoz, Bufferin + Gas-X
Novartis Consumer Health Inc.( NCH) informed customers that it is voluntarily recalling all lots of select bottle packaging configurations from retailers of Excedrin® and NoDoz® products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X Prevention® products with expiry
Read more